← Eichor
Study identifier: NCT07046052 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

Condition: Hip Fracture · Analgesia Post Fracture  ·  Sponsor: University College Cork

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery. It is unclear from the published literature whether an optimal strategy of local anaesthetic delivery has been characterized. Similar doses of local anaesthetic agents can be administered by either continuous infusion or timed intermittent bolus. It is unclear whether one dosing strategy is superior to the other in the context of hip fracture analgesia. The study aims to evaluate the clinical efficacy of both dosing strategies in patients undergoing hip fracture surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Brian D O'Donnell, MBBChBAO MSc FCARCSI MD  ·  +353872780225  ·  briodnl@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cork University HospitalCork, Cork, IrelandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07046052